Injectables

Hikma strengthens US Injectables business through acquisition of Custopharm

Hikma strengthens US Injectables business through acquisition of Custopharm

Hikma strengthens US Injectables business through acquisition of Custopharm

AETOSWire April 12, 2023

Amman,Jordan, 12 April 2023 — Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the...

Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded

Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded

AETOSWire November 3, 2022

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update...